Biodesix (BDSX) Share-based Compensation Growth (1y) (2020 - 2026)
Biodesix (BDSX) Share-based Compensation Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.23% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 2.20% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 8.31% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 58.33% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 5.80% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -0.20% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 500.00% |
| 10 | Biodesix | 220.74 Mn | 195.16 Mn | 21.35 Mn | -93.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.93% |
| Dec 31, 2025 | -101.38% |
| Sep 30, 2025 | -184.42% |
| Jun 30, 2025 | -14.70% |
| Mar 31, 2025 | -63.18% |
| Dec 31, 2024 | 41.08% |
| Sep 30, 2024 | 58.81% |
| Jun 30, 2024 | 15.23% |
| Mar 31, 2024 | 15.74% |
| Dec 31, 2023 | 8,565.38% |
| Sep 30, 2023 | -18.46% |
| Jun 30, 2023 | -22.73% |
| Mar 31, 2023 | 69.47% |
| Dec 31, 2022 | -95.90% |
| Sep 30, 2022 | -15.58% |
| Jun 30, 2022 | 153.80% |
| Mar 31, 2022 | -23.17% |
| Dec 31, 2021 | -64.35% |
| Sep 30, 2021 | 1,286.00% |
| Jun 30, 2021 | 880.00% |